603658 安图生物
已收盘 11-12 15:00:00
资讯
新帖
简况
【机构调研记录】中海基金调研安图生物
证券之星 · 11-11 08:01
【机构调研记录】中海基金调研安图生物
【私募调研记录】域秀资产调研安图生物、安克创新
证券之星 · 11-11 08:01
【私募调研记录】域秀资产调研安图生物、安克创新
安图生物:10月27日接受机构调研,BARING ASSET MANAGEMENT LIMITED(霸菱资产管理有限公司)、保银资产管理有限公司等多家机构参与
证券之星 · 11-10 20:37
安图生物:10月27日接受机构调研,BARING ASSET MANAGEMENT LIMITED(霸菱资产管理有限公司)、保银资产管理有限公司等多家机构参与
安图生物(603658)10月30日主力资金净卖出1430.78万元
证券之星 · 10-31
安图生物(603658)10月30日主力资金净卖出1430.78万元
国金证券:给予安图生物买入评级
证券之星 · 10-27
国金证券:给予安图生物买入评级
股市必读:安图生物新发布《安图生物关于使用自有资金支付募投项目部分款项并以募集资金等额置换的公告》
证券之星 · 10-27
股市必读:安图生物新发布《安图生物关于使用自有资金支付募投项目部分款项并以募集资金等额置换的公告》
安图生物(603658.SH)发布前三季度业绩,归母净利润8.47亿元,同比下降1.45%
智通财经 · 10-26
安图生物(603658.SH)发布前三季度业绩,归母净利润8.47亿元,同比下降1.45%
安图生物最新公告:获乙型流感病毒抗原检测试剂盒医疗器械注册证
证券之星 · 10-21
安图生物最新公告:获乙型流感病毒抗原检测试剂盒医疗器械注册证
安图生物(603658)10月20日主力资金净买入1958.35万元
证券之星 · 10-21
安图生物(603658)10月20日主力资金净买入1958.35万元
安图生物涨6.11%,国金证券一个月前给出“买入”评级
证券之星 · 10-20
安图生物涨6.11%,国金证券一个月前给出“买入”评级
安图生物(603658)10月13日主力资金净卖出161.20万元
证券之星 · 10-14
安图生物(603658)10月13日主力资金净卖出161.20万元
股市必读:安图生物新发布《安图生物关于公司及子公司获得医疗器械注册证的公告》
证券之星 · 10-13
股市必读:安图生物新发布《安图生物关于公司及子公司获得医疗器械注册证的公告》
安图生物(603658)披露使用闲置募集资金进行现金管理赎回公告,10月09日股价上涨0.72%
证券之星 · 10-09
安图生物(603658)披露使用闲置募集资金进行现金管理赎回公告,10月09日股价上涨0.72%
股市必读:安图生物新发布《安图生物关于完成工商变更登记的公告》
证券之星 · 10-09
股市必读:安图生物新发布《安图生物关于完成工商变更登记的公告》
股市必读:安图生物新发布《安图生物关于全资子公司完成医疗器械经营许可证及药品经营许可证变更登记的公告》
证券之星 · 10-08
股市必读:安图生物新发布《安图生物关于全资子公司完成医疗器械经营许可证及药品经营许可证变更登记的公告》
安图生物(603658)9月29日主力资金净买入225.86万元
证券之星 · 09-30
安图生物(603658)9月29日主力资金净买入225.86万元
安图生物(603658)9月28日主力资金净卖出717.15万元
证券之星 · 09-29
安图生物(603658)9月28日主力资金净卖出717.15万元
安图生物涨7.53%,国金证券四周前给出“买入”评级
证券之星 · 09-22
安图生物涨7.53%,国金证券四周前给出“买入”评级
安图生物:公司将于9月30日召开2026年半年度业绩说明会
证券日报 · 09-21
安图生物:公司将于9月30日召开2026年半年度业绩说明会
安图生物获得实用新型专利授权:“一种粪便幽门螺杆菌检测装置”
证券之星 · 09-15
安图生物获得实用新型专利授权:“一种粪便幽门螺杆菌检测装置”
加载更多
公司概况
公司名称:
郑州安图生物工程股份有限公司
所属行业:
医药制造业
上市日期:
2016-09-01
主营业务:
郑州安图生物工程股份有限公司的主营业务是体外诊断试剂和仪器的研发、制造、整合及服务。公司的主要产品是免疫类诊断试剂、微生物检测试剂、分子诊断检测试剂、生化检测试剂、质谱检测试剂、质控品试剂、免疫检测仪器、微生物检测仪器、分子检测仪器、生化检测仪器、质谱检测仪器、血液学检测仪器、检验辅助仪器。
发行价格:
14.58
{"stockData":{"symbol":"603658","market":"SH","secType":"STK","nameCN":"安图生物","latestPrice":38.22,"timestamp":1794466800000,"preClose":39.05,"halted":0,"volume":5426658,"delay":0,"changeRate":-0.0213,"floatShares":571000000,"shares":571000000,"eps":1.8473,"marketStatus":"已收盘","change":-0.83,"latestTime":"11-12 15:00:00","open":39.02,"high":39.05,"low":38.08,"amount":208000000,"amplitude":0.0248,"askPrice":38.22,"askSize":9,"bidPrice":38.21,"bidSize":1,"shortable":0,"etf":0,"ttmEps":1.8473,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1794533400000},"marketStatusCode":5,"adr":0,"adjPreClose":39.05,"symbolType":"stock","openAndCloseTimeList":[[1794447000000,1794454200000],[1794459600000,1794466800000]],"highLimit":42.96,"lowLimit":35.14,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":571424768,"isCdr":false,"pbRate":2.42,"roa":"--","peRate":20.689655,"roe":"9.39%","epsLYR":1.87,"committee":-0.173333,"marketValue":21840000000,"turnoverRate":0.0095,"status":1,"floatMarketCap":21840000000},"requestUrl":"/m/hq/s/603658/","defaultTab":"news","newsList":[{"id":"2682340324","title":"【机构调研记录】中海基金调研安图生物","url":"https://stock-news.laohu8.com/highlight/detail?id=2682340324","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682340324?lang=zh_cn&edition=full","pubTime":"2026-11-11 08:01","pubTimestamp":1794355286,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及11月10日披露的机构调研信息,中海基金近期对1家上市公司进行了调研,相关名单如下:1)安图生物 调研纪要:2025年DRG政策全面落地,检测量有所下降,行业整体承压,当前行业情况逐步暖;2026年前三季度行业的整体检测量呈稳中微升的态势。《全国医疗机构医疗服务价格项目规范及收费指南》落地对公司微生物项目基本无影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111100013062.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0239","603658"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682405393","title":"【私募调研记录】域秀资产调研安图生物、安克创新","url":"https://stock-news.laohu8.com/highlight/detail?id=2682405393","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682405393?lang=zh_cn&edition=full","pubTime":"2026-11-11 08:01","pubTimestamp":1794355276,"startTime":"0","endTime":"0","summary":"根据市场公开信息及11月10日披露的机构调研信息,知名私募域秀资产近期对2家上市公司进行了调研,相关名单如下:1)安图生物 调研纪要:2025年DRG政策全面落地,检测量有所下降,行业整体承压,当前行业情况逐步暖;2026年前三季度行业的整体检测量呈稳中微升的态势。微生物方面,价格基本不受影响,检测量反而有所带动。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/RB2026111100013046.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300866","IE00BPRC5H50.USD","BK0214","00668","IE0003851619.USD","IE00B543WZ88.USD","BK0046","LU2580892862.HKD","BK0239","603658","BK1193","SGXZ81163826.USD","IE0003795394.USD","LU2580892789.USD","BK1186","SGXZ49509284.SGD","IE00B5MMRT66.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682397990","title":"安图生物:10月27日接受机构调研,BARING ASSET MANAGEMENT LIMITED(霸菱资产管理有限公司)、保银资产管理有限公司等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2682397990","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682397990?lang=zh_cn&edition=full","pubTime":"2026-11-10 20:37","pubTimestamp":1794314263,"startTime":"0","endTime":"0","summary":"具体内容如下:问:除前期已披露的投资者关系活动交流沟通外,新增主要互动内容如下:答:2025年,DRG政策全面落地,检测量有所下降,行业整体承压,当前行业情况逐步暖;2026年前三季度行业的整体检测量呈稳中微升的态势。DRG 政策在 2025年全面落地实行,检验套餐已基本解绑到位,对检测量影响不大。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111000044060.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09983","603658","BK0046","BK1542","BK0239","BK1583","BK1229","BK1258"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679264132","title":"安图生物(603658)10月30日主力资金净卖出1430.78万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2679264132","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679264132?lang=zh_cn&edition=full","pubTime":"2026-10-31 08:17","pubTimestamp":1793405850,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月30日收盘,安图生物报收于38.18元,上涨1.81%,换手率1.63%,成交量9.31万手,成交额3.56亿元。近5日资金流向一览见下表:安图生物融资融券信息显示,融资方面,当日融资买入757.89万元,融资偿还1789.62万元,融资净偿还1031.73万元。安图生物主营业务:专注于体外诊断试剂和仪器的研发、制造、整合及服务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103100018162.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","603658","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678110298","title":"国金证券:给予安图生物买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2678110298","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678110298?lang=zh_cn&edition=full","pubTime":"2026-10-27 08:05","pubTimestamp":1793059527,"startTime":"0","endTime":"0","summary":"国金证券股份有限公司甘坛焕,何冠洲近期对安图生物进行研究并发布了研究报告《业绩增长加速,盈利能力显著提升》,给予安图生物买入评级。Q3 公司收入及利润增速回归到双位数增长,免疫诊断及微生物监测类业务均实现了良好拓展。最新盈利预测明细如下:该股最近90天内共有12家机构给出评级,买入评级9家,增持评级3家;过去90天内机构目标均价为41.08。本文数据来源于国金证券股份有限公司,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102700010053.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603658"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678311976","title":"股市必读:安图生物新发布《安图生物关于使用自有资金支付募投项目部分款项并以募集资金等额置换的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2678311976","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678311976?lang=zh_cn&edition=full","pubTime":"2026-10-27 04:28","pubTimestamp":1793046491,"startTime":"0","endTime":"0","summary":"公司公告汇总安图生物关于使用自有资金支付募投项目部分款项并以募集资金等额置换的公告郑州安图生物工程股份有限公司拟在募投项目实施期间,根据实际需要,先行以自有资金支付募投项目部分款项,后续定期以募集资金等额置换。置换操作将在自有资金支付后六个月内完成。公司已通过董事会审议该事项,保荐机构招商证券认为该操作符合相关规定,不影响募投项目正常实施,不存在变相改变募集资金投向或损害股东利益的情形。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102700006218.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603658","BK0046","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678335198","title":"安图生物(603658.SH)发布前三季度业绩,归母净利润8.47亿元,同比下降1.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678335198","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678335198?lang=zh_cn&edition=full","pubTime":"2026-10-26 19:53","pubTimestamp":1793015599,"startTime":"0","endTime":"0","summary":"智通财经APP讯,安图生物(603658.SH)披露2026年第三季度报告,前三季度公司实现营业收入32.4亿元,同比增长3.59%;归属于上市公司股东的净利润8.47亿元,同比下降1.45%;扣非净利润8.28亿元,同比增长1.52%;基本每股收益1.48元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1512662.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["603658"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677474678","title":"安图生物最新公告:获乙型流感病毒抗原检测试剂盒医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2677474678","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677474678?lang=zh_cn&edition=full","pubTime":"2026-10-21 18:51","pubTimestamp":1792579872,"startTime":"0","endTime":"0","summary":"安图生物(603658.SH)公告称,公司近日收到国家药品监督管理局颁发的医疗器械注册证,产品为乙型流感病毒抗原检测试剂盒(磁微粒化学发光法),用于体外定性检测鼻拭子和口咽拭子样本中的乙型流感病毒抗原。该产品为国内外首款磁微粒化学发光法的乙型流感病毒抗原检测试剂盒,进一步丰富公司产品菜单,短期内对经营业绩影响较小。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102100033703.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","BK0046","BK1583","603658","159883","BK1100","BK0239","09996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677610131","title":"安图生物(603658)10月20日主力资金净买入1958.35万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2677610131","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677610131?lang=zh_cn&edition=full","pubTime":"2026-10-21 08:18","pubTimestamp":1792541895,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月20日收盘,安图生物报收于34.19元,上涨6.11%,换手率1.19%,成交量6.8万手,成交额2.28亿元。近5日资金流向一览见下表:安图生物融资融券信息显示,融资方面,当日融资买入1709.24万元,融资偿还1144.38万元,融资净买入564.86万元。安图生物主营业务:专注于体外诊断试剂和仪器的研发、制造、整合及服务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102100006927.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","603658","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676653996","title":"安图生物涨6.11%,国金证券一个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2676653996","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676653996?lang=zh_cn&edition=full","pubTime":"2026-10-20 16:24","pubTimestamp":1792484655,"startTime":"0","endTime":"0","summary":"今日安图生物涨6.11%,收盘报34.19元。2026年8月25日,国金证券研究员甘坛焕,何冠洲发布了对安图生物的研报《海外创新加速突破,拓展长期增长点》,该研报对安图生物给出“买入”评级。研报中预计公司2026-2028年归母净利润分别为10.16、11.38、13.55亿元,同比-5%、+12%、+19%,现价对应PE为19、17、14倍,维持“买入”评级。安图生物个股概况:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102000024258.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603658"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675396815","title":"安图生物(603658)10月13日主力资金净卖出161.20万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675396815","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675396815?lang=zh_cn&edition=full","pubTime":"2026-10-14 08:32","pubTimestamp":1791937927,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月13日收盘,安图生物报收于32.45元,下跌1.93%,换手率0.41%,成交量2.35万手,成交额7652.58万元。近5日资金流向一览见下表:安图生物融资融券信息显示,融资方面,当日融资买入506.16万元,融资偿还504.25万元,融资净买入1.91万元。安图生物主营业务:专注于体外诊断试剂和仪器的研发、制造、整合及服务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101400007323.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0046","603658"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675105804","title":"股市必读:安图生物新发布《安图生物关于公司及子公司获得医疗器械注册证的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2675105804","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675105804?lang=zh_cn&edition=full","pubTime":"2026-10-13 01:53","pubTimestamp":1791827590,"startTime":"0","endTime":"0","summary":"公司公告汇总:安图生物及子公司获多项医疗器械注册证,涵盖HIV核酸检测试剂盒、全自动凝血分析仪等,注册证有效期均为5年。公司公告汇总安图生物关于公司及子公司获得医疗器械注册证的公告郑州安图生物工程股份有限公司及全资子公司安图实验仪器(郑州)、二级子公司郑州标源近日收到国家药品监督管理局和河南省药品监督管理局颁发的医疗器械注册证。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101300001865.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","159883","603658","BK1583","09996","BK1100","BK0239","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674086810","title":"安图生物(603658)披露使用闲置募集资金进行现金管理赎回公告,10月09日股价上涨0.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2674086810","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674086810?lang=zh_cn&edition=full","pubTime":"2026-10-09 23:03","pubTimestamp":1791558198,"startTime":"0","endTime":"0","summary":"截至2026年10月9日收盘,安图生物报收于33.45元,较前一交易日上涨0.72%,最新总市值为191.14亿元。公告显示,公司于2026年10月9日赎回使用非公开发行股票闲置募集资金购买的可转让大额存单1,000万元,获得利息收益21.14万元;同日赎回通用回购逆回购3,000万元,获得利息收益3.62万元。公司此前已履行相关审议程序,授权使用闲置募集资金进行现金管理。截至公告日,最近十二个月累计实际收益3,310.96万元,尚未收回本金金额141,000万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900039035.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0239","603658"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674017260","title":"股市必读:安图生物新发布《安图生物关于完成工商变更登记的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2674017260","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674017260?lang=zh_cn&edition=full","pubTime":"2026-10-09 01:26","pubTimestamp":1791480369,"startTime":"0","endTime":"0","summary":"当日关注点交易信息汇总:10月8日主力资金净流出995.62万元,占总成交额7.96%; 公司公告汇总:安图生物已完成经营范围变更及《公司章程》修订的工商登记手续,取得换发的新《营业执照》。公司公告汇总安图生物关于完成工商变更登记的公告郑州安图生物工程股份有限公司于2026年8月24日召开第五届董事会第十三次会议,审议通过变更公司经营范围暨修订《公司章程》的议案,并经2026年9月14日第一次临时股东大会审议通过。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900001681.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603658","BK0046","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673301493","title":"股市必读:安图生物新发布《安图生物关于全资子公司完成医疗器械经营许可证及药品经营许可证变更登记的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2673301493","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673301493?lang=zh_cn&edition=full","pubTime":"2026-10-08 01:10","pubTimestamp":1791393017,"startTime":"0","endTime":"0","summary":"截至2026年9月30日收盘,安图生物报收于34.08元,上涨1.4%,换手率0.62%,成交量3.55万手,成交额1.21亿元。医疗器械经营许可证经营范围涵盖多个类别,经营方式为批零兼营并提供运输、贮存服务,许可期限至2030年5月21日;药品经营许可证经营范围为体外诊断试剂(药品),含冷藏药品,经营方式为批发,有效期至2029年6月27日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100800000754.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","603658","BK0046","BK0239","BK1100","09996","159883","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671122529","title":"安图生物(603658)9月29日主力资金净买入225.86万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2671122529","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671122529?lang=zh_cn&edition=full","pubTime":"2026-09-30 08:33","pubTimestamp":1790728432,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年9月29日收盘,安图生物报收于33.61元,下跌1.52%,换手率0.48%,成交量2.73万手,成交额9245.61万元。近5日资金流向一览见下表:安图生物融资融券信息显示,融资方面,当日融资买入1173.34万元,融资偿还979.3万元,融资净买入194.04万元。安图生物主营业务:专注于体外诊断试剂和仪器的研发、制造、整合及服务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000006794.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0046","603658"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671126645","title":"安图生物(603658)9月28日主力资金净卖出717.15万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2671126645","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671126645?lang=zh_cn&edition=full","pubTime":"2026-09-29 08:21","pubTimestamp":1790641309,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年9月28日收盘,安图生物报收于34.13元,上涨1.43%,换手率0.66%,成交量3.8万手,成交额1.3亿元。近5日资金流向一览见下表:安图生物融资融券信息显示,融资方面,当日融资买入1427.53万元,融资偿还1527.67万元,融资净偿还100.14万元。安图生物主营业务:专注于体外诊断试剂和仪器的研发、制造、整合及服务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092900007084.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","603658","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669626117","title":"安图生物涨7.53%,国金证券四周前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2669626117","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669626117?lang=zh_cn&edition=full","pubTime":"2026-09-22 16:37","pubTimestamp":1790066276,"startTime":"0","endTime":"0","summary":"今日安图生物涨7.53%,收盘报34.97元。2026年8月25日,国金证券研究员甘坛焕,何冠洲发布了对安图生物的研报《海外创新加速突破,拓展长期增长点》,该研报对安图生物给出“买入”评级。研报中预计公司2026-2028年归母净利润分别为10.16、11.38、13.55亿元,同比-5%、+12%、+19%,现价对应PE为19、17、14倍,维持“买入”评级。安图生物个股概况:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092200028574.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603658"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669165982","title":"安图生物:公司将于9月30日召开2026年半年度业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2669165982","media":"证券日报 ","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669165982?lang=zh_cn&edition=full","pubTime":"2026-09-21 19:31","pubTimestamp":1789990260,"startTime":"0","endTime":"0","summary":"证券日报网讯9月21日,安图生物发布公告称,公司将于2026年9月30日16:00-17:00召开2026年半年度业绩说明会。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-21/doc-inisqvrw5750709.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-21/doc-inisqvrw5750709.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["603658","BK0046","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667369350","title":"安图生物获得实用新型专利授权:“一种粪便幽门螺杆菌检测装置”","url":"https://stock-news.laohu8.com/highlight/detail?id=2667369350","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667369350?lang=zh_cn&edition=full","pubTime":"2026-09-15 03:32","pubTimestamp":1789414323,"startTime":"0","endTime":"0","summary":"证券之星消息,根据天眼查APP数据显示安图生物新获得一项实用新型专利授权,专利名为“一种粪便幽门螺杆菌检测装置”,专利申请号为CN202521850648.8,授权日为2026年9月15日。上述粪便幽门螺杆菌检测装置,解决了现有检测装置步骤繁琐、需频繁直视样本的技术问题,实现了操作简便,无需频繁直视样本的技术效果。今年以来安图生物新获得专利授权27个,较去年同期增加了68.75%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091500002407.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603658","BK0046","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1794522428607,"stockEarnings":[{"period":"1week","weight":-0.0443},{"period":"1month","weight":0.1778},{"period":"3month","weight":0.1351},{"period":"6month","weight":0.1842},{"period":"1year","weight":0.007},{"period":"ytd","weight":0.123}],"compareEarnings":[{"period":"1week","weight":-0.0092},{"period":"1month","weight":-0.0382},{"period":"3month","weight":-0.0691},{"period":"6month","weight":-0.116},{"period":"1year","weight":-0.0861},{"period":"ytd","weight":-0.0789}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"郑州安图生物工程股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"34932人(较上一季度增加0.42%)","perCapita":"16358股","listingDate":"2016-09-01","address":"河南省郑州市管城回族区经济技术开发区经北一路87号","registeredCapital":"57142万元","survey":" 郑州安图生物工程股份有限公司的主营业务是体外诊断试剂和仪器的研发、制造、整合及服务。公司的主要产品是免疫类诊断试剂、微生物检测试剂、分子诊断检测试剂、生化检测试剂、质谱检测试剂、质控品试剂、免疫检测仪器、微生物检测仪器、分子检测仪器、生化检测仪器、质谱检测仪器、血液学检测仪器、检验辅助仪器。","listedPrice":14.58},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"安图生物(603658)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供安图生物(603658)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"安图生物,603658,安图生物股票,安图生物股票老虎,安图生物股票老虎国际,安图生物行情,安图生物股票行情,安图生物股价,安图生物股市,安图生物股票价格,安图生物股票交易,安图生物股票购买,安图生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"安图生物(603658)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供安图生物(603658)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}